HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lakhani, S R Search for Related Content PubMed PubMed Citation Articles by Lakhani, S R

Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer

The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, Fulham Road, London SW3 6JB, UK

Correspondence: Professor Lakhani lakhani{at}icr.ac.uk

Breast cancer is a common solid malignancy in women. Over the past decade, much progress has been made in understanding the biology of breast cancer. The use of molecular and immunohistochemical techniques is providing insights that will allow us to tailor the management of patients with breast cancer. In this review, progress in the understanding of lobular carcinoma in situ and atypical ductal hyperplasia, the use of the molecular marker CerbB2, and information gained from the morphological analysis of tumours arising in patients with BRCA1 and BRCA2 mutations is discussed. J Clin Pathol: Mol Pathol(J Clin Pathol: Mol Pathol 2001;54:281–284)

Key Words: breast cancer • lobular carcinoma in situ • atypical ductal hyperplasia • CerbB2, • BRCA1 mutation • BRCA2 mutation • molecular markers

This article has been cited by other articles:

				A P M Jongsma, J M J Piek, R P Zweemer, R H M Verheijen, J W T Klein Gebbinck, G J van Kamp, I J Jacobs, P Shaw, P J van Diest, and P Kenemans Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer Mol. Pathol., October 1, 2002; 55(5): 305 - 309. [Abstract] [Full Text] [PDF]

				R Roylance Methods of molecular analysis: assessing losses and gains in tumours Mol. Pathol., February 1, 2002; 55(1): 25 - 28. [Abstract] [Full Text] [PDF]